Private limited company · Bærum
SANA PHARMA MEDICAL AS
ActiveWholesale of pharmaceutical and medical goods (46.460)
The life line 1997–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 91.7m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
SANA PHARMA MEDICAL AS is a private limited company in Bærum, founded in 1994, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Heidi Tveit, and the chair of the board is Heidi Tveit. In 2025 the company had NOK 91.7m in operating revenue and a net profit of NOK −8.9m. The largest owner is SANA PHARMA MANAGEMENT AS with 100.0%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 6 Oct 2026
- Endring av revisor
- Number of employees 9 → 10
- Annual accounts filed 2024 → 2025
- Godkjent årsregnskap
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteOperating loss three years running, 2023–2025
- NoteChanged auditor 6 Oct 2026
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 91.7m in 2025
Revenue
NOK 91.7m
+36.4% from 2024
20232025
Operating profit
NOK −3.6m
+46.4% from 2024
20232025
Net profit
NOK −8.9m
+10.0% from 2024
20232025
Equity
NOK 13.5m
+327.4% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 13%
- Depreciation 2%
- Other operating costs 54%
- Not specified in the source 35%
Costs exceeded revenue: the operating result was NOK −3.6m.
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 13.6%
- SANA PHARMA MEDICAL AS, 2025
- Industry median, assumed: NOK 8.5m · 4.3% · 41.6% · +7.3%
Equity NOK 13.5m14% of the assets (NOK 99.1m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.
Finances
§ 06 Accounts
28 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 91,713 | 67,242 | 56,624 | |
| Operating profit | −3,644 | −6,793 | −9,200 | |
| Profit before tax | −8,869 | −9,844 | −10,465 | |
| Net profit | −8,862 | −9,844 | −10,465 | |
| Total assets | 99,074 | 80,666 | 65,792 | |
| Equity | 13,466 | −5,921 | 3,922 | |
| Liabilities | 85,608 | 86,587 | 61,869 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 28 years →
Management and ownership
§ 07 Officers
5 officers now
- Heidi TveitChief executive since 2014
- ZENERA ASAccountant
- Heidi TveitChair of the board since 2023
- CEDRA NORGE ASAuditor since 2026
- Morten Brennesvik-JensenBoard member since 2021
Source: the Brønnøysund Register Centre, read 7 Oct 2026 · All 5 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
Styret i fellesskap.
May sign for the company:
Styret i fellesskap.
Power of procuration:
Daglig leder alene.
The board has no authorisation in force now.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 23 Aug 2026
Management and ownership
§ 09 Owners
1 shareholder · largest 100.0%
| Owner | Share |
|---|---|
| SANA PHARMA MANAGEMENT AS | 100.0% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →
Management and ownership
§ 10 Group
2 subsidiaries
- EIR PHARMA AS100%
- PULSAPOTEKET SKØYEN AS100%
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
9 connections
- Person
- Company
2 people link SANA PHARMA MEDICAL AS to 6 other companies: Morten Brennesvik-Jensen 5 and Heidi Tveit 3.
Source: the Brønnøysund Register Centre, read 7 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
30 since 2015
Events per year
20152026
Since 2015: 119 announcements and 2 register changes. Most happened in 2025 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 30 events →
Events and registers
§ 14 Notices
119, latest 6 Oct 2026
- Revisor
- Godkjente årsregnskap
- Revisor
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 119 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 20 Feb 1995
- VATRegistered
- The Register of Business EnterprisesRegistered 15 Feb 1994
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Produktutvikling i farmasøytisk industri samt deltakelse i andre foretak.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 46.460
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
7 questions
- Who is the chief executive of SANA PHARMA MEDICAL AS?
Heidi Tveit, since 2014. § 07 - Who owns SANA PHARMA MEDICAL AS?
1 shareholder. It is SANA PHARMA MANAGEMENT AS with 100.0%. § 09 - What was the revenue in 2025?
NOK 91.7m in the company. § 06 - Who can sign for SANA PHARMA MEDICAL AS?
Styret i fellesskap. § 08 - Who is the auditor?
CEDRA NORGE AS, from 6 Oct 2026. § 07 - Where is SANA PHARMA MEDICAL AS based?
Philip Pedersens vei 20, 1366 Lysaker. - When was SANA PHARMA MEDICAL AS founded?
11 Jan 1994, registered in the Register of Business Enterprises 15 Feb 1994. § 16
The answers come from the sections linked to, with their sources.